NCT04098068 2025-03-30
Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Adlai Nortye Biopharma Co., Ltd.
University of Pittsburgh